2015 BMT Tandem Meetings: Poster Session 1: Histocompatibility/Alternative Stem Cell Sources

187

MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Medhat Askar, MD, PhD, Cleveland Clinic; Ronald Sobecks, MD, Taussig Cancer Institute, Cleveland Clinic; Stephen Spellman, MBS, CIBMTR/Minneapolis Campus; Michael Haagenson, MS, CIBMTR; Tao Wang, PhD, Medical College of Wisconsin; Dawn Thomas, BA, Cleveland; Aiwen Zhang, PhD, Cleveland Clinic; Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center; Marcelo Fernandez-Vina, PhD, Stanford University Medical School

189

Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Parastoo Dahi, MD, Memorial Sloan Kettering Cancer Center; Doris M. Ponce, MD, Memorial Sloan Kettering Cancer Center; Courtney Byam, BS, Memorial Sloan Kettering Cancer Center; Sean Devlin, PhD, Memorial Sloan Kettering Cancer Center; Marissa Lubin, BA, Memorial Sloan Kettering Cancer Center; Emily Lauer, BS, Memorial Sloan Kettering Cancer Center; Melissa Sideroff, BA, Memorial Sloan Kettering Cancer Center; Deborah Wells, MA, Memorial Sloan Kettering Cancer Center; Esperanza Papadopoulos, MD, Memorial Sloan Kettering Cancer Center; Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center; James W Young, MD, FACP, Memorial Sloan Kettering Cancer Center; Nancy A Kernan, MD, Memorial Sloan Kettering Cancer Center; Andromachi Scaradavou, MD, Memorial Sloan Kettering Cancer Center; Juliet Barker, MBBS (Hons) FRACP, Memorial Sloan Kettering Cancer Center

190

The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
Pietro Crivello, PhD, Institute for Experimental Cellular Therapy, University Hospital Essen; Laura Zito, BSc, Unit of Molecular and Functional Immunogenetics, San Raffaele Scientific Institute; Elisabetta Zino, BSc, Unit of Molecular and Functional Immunogenetics, San Raffaele Scientific Institute; Martin Maiers, National Marrow Donor Program; Luca Vago, MD PhD, Unit of Molecular and Functional Immunogenetics, San Raffaele Scientific Institute; Fabio Ciceri, MD, San Raffaele Scientific Institute; Katharina Fleischhauer, MD, University Hospital Essen

191

Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Kazuhiro Ikegame, MD, PhD, Hyogo College of Medicine; Katsuji Kaida, MD, PhD, Hyogo College of Medicine; Shinichi Ishii, MD, Hyogo College of Medicine; Satoshi Yoshihara, MD, PhD, Hyogo College of Medicine; Kyoko Taniguchi, MD, PhD, Hyogo College of Medicine; Takayuki Inoue, MD, Hyogo College of Medicine; Hiroya Tamaki, MD, PhD, Hyogo College of Medicine; Masaya Okada, MD, PhD, Hyogo College of Medicine; Toshihiro Soma, MD, PhD, Hyogo College of Medicine; Hiroyasu Ogawa, MD, PhD, Hyogo College of Medicine

192

Pretransplant Sirolimus Improves Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Patients with Severe Aplastic Anemia
Sarita Jaiswal, MD, MANASHI CHAKRABARTI FOUNDATION; Aditi Chakrabarti, MD, MANASHI CHAKRABARTI FOUNDATION; Suparno Chakrabarti, MD, FRCPATH, MANASHI CHAKRABARTI FOUNDATION

193

The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Junya Kanda, MD, Saitama Medical Center, Jichi Medical University; Kazuhiro Ikegame, MD, PhD, Hyogo College of Medicine; Shigeo Fuji, MD, National Cancer Center Hospital; Takahiro Fukuda, MD, PhD, National Cancer Center Hospital; Mineo Kurokawa, MD, The University of Tokyo Hospital; Hiroyasu Ogawa, MD, PhD, Hyogo College of Medicine; Kazuteru Ohashi, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital; Heiwa Kanamori, MD, Kanagawa Cancer Center; Jun Ishikawa, MD, Osaka Medical Center for Cancer and Cardiovascular Diseases; Masami Inoue, MD, Osaka Medical Center and Research Institute for Maternal and Child Health; Tatsuo Ichinohe, MD, Hiroshima University Hospital; Yoshiko Atsuta, MD, PhD, Nagoya University Graduate School of Medicine; Yoshinobu Kanda, MD, Saitama Medical Center, Jichi Medical University

194

HLA-C Mismatch without Impact on Outcome after Allogeneic HSCT
Jonas Mattsson, MD PhD, Karolinska University Hospital; Michael Uhlin, PhD, Karolinska University Hospital; Dan Hauzenberger, MD, Karolinska University Hospital; Mats Remberger, PhD, Karolinska University Hospital

195

Successful Engraftment and Full Donor Chimerism in Patients Undergoing Second Allogeneic Stem Cell Transplantation with Umbilical Cord Blood
Rachel B. Salit, MD, Fred Hutchinson Cancer Research Center; Filippo Milano, MD, PhD, Fred Hutchinson Cancer Research Center; David C. Oliver, Fred Hutchinson Cancer Research Center; Ivy Riffkin, RN, Fred Hutchinson Cancer Research Center; Nancy L. Anderson, RN, Fred Hutchinson Cancer Research Center; Colleen Delaney, MD, MSc, Fred Hutchinson Cancer Research Center

196

Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Hiroya Tamaki, MD, PhD, Hyogo College of Medicine; Kazuhiro Ikegame, MD, PhD, Hyogo College of Medicine; Satoshi Yoshihara, MD, PhD, Hyogo College of Medicine; Katsuji Kaida, MD, PhD, Hyogo College of Medicine; Takayuki Inoue, MD, Hyogo College of Medicine; Masaya Okada, MD, PhD, Hyogo College of Medicine; Toshihiro Soma, MD, PhD, Hyogo College of Medicine; Hiroyasu Ogawa, MD, PhD, Hyogo College of Medicine

197

Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
Kevin Tram, B.A., National Marrow Donor Program; Gretta Stritesky, Ph.D, National Marrow Donor Program; Kimberly Wadsworth, Ph.D., National Marrow Donor Program; Deidre M. Kiefer, M.P.H., Center for International Blood and Marrow Transplant Research, National Marrow Donor Program; Jennifer Ng, Ph.D., Georgetown University; Claudio Anasetti, MD, H. Lee Moffitt Cancer Center and Research Institute; Jason Dehn, M.P.H., National Marrow Donor Program

198

Complete Loss of HLA Class I Heterozygosity in a Patient with Acute Myeloid Leukemia
Christine Zollikofer, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT); Mark Ringhoffer, MD, 3rd Department of Medicine, Municipal Hospital, Karlsruhe; Lukas K�ndgen, MD, 3rd Department of Medicine, Municipal Hospital, Karlsruhe; Daniel F�rst, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT); Hubert Schrezenmeier, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT); Joannis Mytilineos, MD, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm gGmbH (IKT)